Back to search
FDAFDA · Food and drugs·Recall number D-0903-2023

Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39

Published July 19, 2023 · Recall initiated: February 9, 2023

Summary

FDA records drug Class II recall D-0903-2023, published July 19, 2023 and initiated February 9, 2023. Recalling firm: L. Perrigo Company; Status: Terminated; Reported quantity: 16,200 cartons; Lot: Lot #: 2DV1925, Exp. date 06/23. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
L. Perrigo Company
Distributor
Nationwide within the USA
Lot
Lot #: 2DV1925, Exp. date 06/23
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg, 30-count cartons, Distributed By: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895. NDC 69842-0914-39 recalled?

Yes. FDA published recall D-0903-2023 on July 19, 2023. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter